Gsk Plc Adr (GSK)

Mar 28, 2025

Is GSK plc (GSK) the Best ADR Stock to Buy According to Hedge Funds? - Insider Monkey

Mar 28, 2025

Mar 28, 2025

Deadline Alert: GSK plc. (GSK) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - TradingView

Mar 28, 2025

Mar 27, 2025

GSK's Vaccine and HIV Portfolios Support Ongoing Innovation in Oncology and Immunology - Morningstar

Mar 27, 2025

Mar 26, 2025

GSK Secures FDA Nod for Oral Antibiotic to Treat Urinary Tract Infection - Yahoo Finance

Mar 26, 2025

Mar 23, 2025

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of GSK - GlobeNewswire Inc.

Mar 23, 2025

Mar 21, 2025

Deadline Alert: GSK plc. (GSK) Investors Who Lost Money - GlobeNewswire

Mar 21, 2025

Mar 19, 2025

How Do Things Look For GSK Plc ADR (NYSE: GSK) In The Short-Term? - Stocks Register

Mar 19, 2025

Mar 18, 2025

GSK Lead Plaintiff Deadline Approaching – Contact Robbins - GlobeNewswire

Mar 18, 2025

Mar 18, 2025

GSK Lead Plaintiff Deadline Approaching – Contact Robbins LLP for Information About How to Lead the GSK PLC Class Action - TradingView

Mar 18, 2025

Mar 14, 2025

Why GSK (GSK) is a Top Momentum Stock for the Long-Term - Yahoo Finance

Mar 14, 2025

Mar 13, 2025

Bioengineered Protein Drugs Market Size to Cross USD 672.7 Billion by 2034, Growing at a CAGR of 6.2% - GlobeNewswire Inc.

Mar 13, 2025

Mar 13, 2025

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick - Yahoo Finance

Mar 13, 2025

Mar 12, 2025

GILD Data on Once-Yearly Lenacapavir for HIV Prevention Positive - Zacks Investment Research

Mar 12, 2025

Mar 11, 2025

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GSK plc of Class Action Lawsuit and Upcoming DeadlinesGSK - PR Newswire

Mar 11, 2025

Mar 11, 2025

IONS/AZN Get FDA Nod for Amyloidosis Drug, Wainzua in Europe - Zacks Investment Research

Mar 11, 2025

Mar 10, 2025

The Best Defensive Stocks to Buy Now - Morningstar

Mar 10, 2025

Mar 06, 2025

Biotech Stocks Roundup: CMRX Up on JAZZ Bid, MRNA Up on Updates & More - Yahoo Finance

Mar 06, 2025

Mar 06, 2025

The Best Women-Led Companies to Own: 2025 Edition - Morningstar

Mar 06, 2025

Mar 04, 2025

GSK’s Stock Market Puzzle: Piecing Together 2023’s Performance - The InvestChronicle

Mar 04, 2025

Mar 03, 2025

Why weight-loss drugs are the top target of Medicare price negotiations - Equities News

Mar 03, 2025

Feb 25, 2025

GSK Securities Class Action: GSK PLC Investors Should Contact Robbins LLP for Information About the Lead Plaintiff Deadline in the GSK Class Action Lawsuit - The Malaysian Reserve

Feb 25, 2025

Feb 25, 2025

5 Undervalued Stocks That Crushed Q4 Earnings - Morningstar

Feb 25, 2025

Feb 14, 2025

Shareholder Rights Law Firm Robbins LLP Reminds GSK Investors with Large Losses to Seek Advice on Leading the GSK PLC Class Action - PR Newswire

Feb 14, 2025

Feb 14, 2025

A closer look at Gold Fields Ltd ADR’s (GFI) current quarter earnings projections - US Post News

Feb 14, 2025

Feb 11, 2025

Law Offices of Frank R. Cruz Encourages GSK plc. (GSK) Investors To Inquire About Securities Fraud Class Action - Business Wire

Feb 11, 2025

Feb 11, 2025

Deadline Approaching: GSK plc. (GSK) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith - Business Wire

Feb 11, 2025

Feb 10, 2025

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages GSK plc. (GSK) Investors To Inquire About Securities Fraud Class Action - Business Wire

Feb 10, 2025

Feb 07, 2025

Is GSK Plc ADR (GSK) worth investing in despite its undervalued state? - US Post News

Feb 07, 2025

Feb 07, 2025

Chewy Inc (CHWY) is an excellent investment, but the stock is overvalued/undervalued right now - US Post News

Feb 07, 2025

Feb 07, 2025

Law Offices of Howard G. Smith Encourages GSK plc. (GSK) Investors To Inquire About Securities Fraud Class Action - Business Wire

Feb 07, 2025

Feb 06, 2025

GSK PLC Stockholder Notice: Shareholder Rights Law Firm - GlobeNewswire

Feb 06, 2025